Diabetic neuropathy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

A 55-year-old female presents to your clinic with pain in the back and associated tingling, numbness, and pain in both her legs for the past year. The symptoms are worse at night. She has an antalgic broad-based gait and has been using a walker to get around. She was working as a school teacher, but has been on short-term disability for the last 4 months. She is depressed about her prognosis and is asking you to fix her so she can return to work. 1. How prevalent is this disease presentation? Could you explain some of the epidemiologic features of this disease? Are there any cost concerns? The 2011 Diabetes fact sheet published by the Centers for Disease Control confirmed that 25 million Americans have diabetes, a disease now affecting one in every four patients. Five percent of these individuals have type 1 diabetes mellitus (DM) and 95% have type 2 DM. Diabetic patients have a life time prevalence of 60% of developing diabetic neuropathy.[1] There are currently 8 million people in the USA who have symptomatic diabetic polyneuropathy. Diabetic polyneuropathy is a length-dependent disorder of peripheral nerve fibers, characterized by a distal-to-proximal loss of peripheral nerve axons and function. The progression of disease from painful neuropathy to loss of sensation and development of foot ulcers and amputations causes a significant burden to society both in social and financial ways. The cost of diabetic neuropathy was estimated to be $50 billion in 2007, which is 25% of total costs related to DM. This number is expected to rise exponentially.[2] Patients with painful diabetic peripheral neuropathy (PDPN) are more likely to have foot ulcers and amputations, further increasing the burden of the disease and decreasing quality of life for those affected. The prevalence of diabetic polyneuropathy (DPN) and PDPN increases with age, duration of diabetes, and worsening of glucose tolerance. The overall prevalence of PDPN in the diabetic population is 15%.[3]

Original languageEnglish (US)
Title of host publicationCase Studies in Pain Management
PublisherCambridge University Press
Pages52-63
Number of pages12
ISBN (Print)9781107281950, 9781107682894
DOIs
StatePublished - Jan 1 2014

Fingerprint

Diabetic Neuropathies
Peripheral Nervous System Diseases
Foot Ulcer
Peripheral Nerves
Amputation
Costs and Cost Analysis
Pain Clinics
Return to Work
Hypesthesia
Back Pain
Centers for Disease Control and Prevention (U.S.)
Type 1 Diabetes Mellitus
Gait
Nerve Fibers
Type 2 Diabetes Mellitus
Axons
Disease Progression
Leg
Diabetes Mellitus
Quality of Life

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Doulatram, G., & Raj, T. (2014). Diabetic neuropathy. In Case Studies in Pain Management (pp. 52-63). Cambridge University Press. https://doi.org/10.1017/CBO9781107281950.009

Diabetic neuropathy. / Doulatram, Gulshan; Raj, Tilak.

Case Studies in Pain Management. Cambridge University Press, 2014. p. 52-63.

Research output: Chapter in Book/Report/Conference proceedingChapter

Doulatram, G & Raj, T 2014, Diabetic neuropathy. in Case Studies in Pain Management. Cambridge University Press, pp. 52-63. https://doi.org/10.1017/CBO9781107281950.009
Doulatram G, Raj T. Diabetic neuropathy. In Case Studies in Pain Management. Cambridge University Press. 2014. p. 52-63 https://doi.org/10.1017/CBO9781107281950.009
Doulatram, Gulshan ; Raj, Tilak. / Diabetic neuropathy. Case Studies in Pain Management. Cambridge University Press, 2014. pp. 52-63
@inbook{7eb50cd0e8864628a1f02955d0c0fa90,
title = "Diabetic neuropathy",
abstract = "A 55-year-old female presents to your clinic with pain in the back and associated tingling, numbness, and pain in both her legs for the past year. The symptoms are worse at night. She has an antalgic broad-based gait and has been using a walker to get around. She was working as a school teacher, but has been on short-term disability for the last 4 months. She is depressed about her prognosis and is asking you to fix her so she can return to work. 1. How prevalent is this disease presentation? Could you explain some of the epidemiologic features of this disease? Are there any cost concerns? The 2011 Diabetes fact sheet published by the Centers for Disease Control confirmed that 25 million Americans have diabetes, a disease now affecting one in every four patients. Five percent of these individuals have type 1 diabetes mellitus (DM) and 95{\%} have type 2 DM. Diabetic patients have a life time prevalence of 60{\%} of developing diabetic neuropathy.[1] There are currently 8 million people in the USA who have symptomatic diabetic polyneuropathy. Diabetic polyneuropathy is a length-dependent disorder of peripheral nerve fibers, characterized by a distal-to-proximal loss of peripheral nerve axons and function. The progression of disease from painful neuropathy to loss of sensation and development of foot ulcers and amputations causes a significant burden to society both in social and financial ways. The cost of diabetic neuropathy was estimated to be $50 billion in 2007, which is 25{\%} of total costs related to DM. This number is expected to rise exponentially.[2] Patients with painful diabetic peripheral neuropathy (PDPN) are more likely to have foot ulcers and amputations, further increasing the burden of the disease and decreasing quality of life for those affected. The prevalence of diabetic polyneuropathy (DPN) and PDPN increases with age, duration of diabetes, and worsening of glucose tolerance. The overall prevalence of PDPN in the diabetic population is 15{\%}.[3]",
author = "Gulshan Doulatram and Tilak Raj",
year = "2014",
month = "1",
day = "1",
doi = "10.1017/CBO9781107281950.009",
language = "English (US)",
isbn = "9781107281950",
pages = "52--63",
booktitle = "Case Studies in Pain Management",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Diabetic neuropathy

AU - Doulatram, Gulshan

AU - Raj, Tilak

PY - 2014/1/1

Y1 - 2014/1/1

N2 - A 55-year-old female presents to your clinic with pain in the back and associated tingling, numbness, and pain in both her legs for the past year. The symptoms are worse at night. She has an antalgic broad-based gait and has been using a walker to get around. She was working as a school teacher, but has been on short-term disability for the last 4 months. She is depressed about her prognosis and is asking you to fix her so she can return to work. 1. How prevalent is this disease presentation? Could you explain some of the epidemiologic features of this disease? Are there any cost concerns? The 2011 Diabetes fact sheet published by the Centers for Disease Control confirmed that 25 million Americans have diabetes, a disease now affecting one in every four patients. Five percent of these individuals have type 1 diabetes mellitus (DM) and 95% have type 2 DM. Diabetic patients have a life time prevalence of 60% of developing diabetic neuropathy.[1] There are currently 8 million people in the USA who have symptomatic diabetic polyneuropathy. Diabetic polyneuropathy is a length-dependent disorder of peripheral nerve fibers, characterized by a distal-to-proximal loss of peripheral nerve axons and function. The progression of disease from painful neuropathy to loss of sensation and development of foot ulcers and amputations causes a significant burden to society both in social and financial ways. The cost of diabetic neuropathy was estimated to be $50 billion in 2007, which is 25% of total costs related to DM. This number is expected to rise exponentially.[2] Patients with painful diabetic peripheral neuropathy (PDPN) are more likely to have foot ulcers and amputations, further increasing the burden of the disease and decreasing quality of life for those affected. The prevalence of diabetic polyneuropathy (DPN) and PDPN increases with age, duration of diabetes, and worsening of glucose tolerance. The overall prevalence of PDPN in the diabetic population is 15%.[3]

AB - A 55-year-old female presents to your clinic with pain in the back and associated tingling, numbness, and pain in both her legs for the past year. The symptoms are worse at night. She has an antalgic broad-based gait and has been using a walker to get around. She was working as a school teacher, but has been on short-term disability for the last 4 months. She is depressed about her prognosis and is asking you to fix her so she can return to work. 1. How prevalent is this disease presentation? Could you explain some of the epidemiologic features of this disease? Are there any cost concerns? The 2011 Diabetes fact sheet published by the Centers for Disease Control confirmed that 25 million Americans have diabetes, a disease now affecting one in every four patients. Five percent of these individuals have type 1 diabetes mellitus (DM) and 95% have type 2 DM. Diabetic patients have a life time prevalence of 60% of developing diabetic neuropathy.[1] There are currently 8 million people in the USA who have symptomatic diabetic polyneuropathy. Diabetic polyneuropathy is a length-dependent disorder of peripheral nerve fibers, characterized by a distal-to-proximal loss of peripheral nerve axons and function. The progression of disease from painful neuropathy to loss of sensation and development of foot ulcers and amputations causes a significant burden to society both in social and financial ways. The cost of diabetic neuropathy was estimated to be $50 billion in 2007, which is 25% of total costs related to DM. This number is expected to rise exponentially.[2] Patients with painful diabetic peripheral neuropathy (PDPN) are more likely to have foot ulcers and amputations, further increasing the burden of the disease and decreasing quality of life for those affected. The prevalence of diabetic polyneuropathy (DPN) and PDPN increases with age, duration of diabetes, and worsening of glucose tolerance. The overall prevalence of PDPN in the diabetic population is 15%.[3]

UR - http://www.scopus.com/inward/record.url?scp=84952815454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952815454&partnerID=8YFLogxK

U2 - 10.1017/CBO9781107281950.009

DO - 10.1017/CBO9781107281950.009

M3 - Chapter

SN - 9781107281950

SN - 9781107682894

SP - 52

EP - 63

BT - Case Studies in Pain Management

PB - Cambridge University Press

ER -